PDE4 inhibitor (apremilast) in pemphigoid
Recruiting
- Conditions
- Pemphigoid Pemfigioid
- Registration Number
- NL-OMON21799
- Lead Sponsor
- MCG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Adult patients with recently diagnosed mild to moderate localized or generalized cutaneous pemphigoid, or patients that were in complete remission without treatment that have a mild-moderate flare-up of the disease.
Exclusion Criteria
Contradiction or known allergy for PDE4 inhibitors.
Women of childbearing potential without contraception, women who are pregnant or planning to become pregnant or who are lactating.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Partial remission
- Secondary Outcome Measures
Name Time Method Drug survival<br /><br>Complete remission